A citation-based method for searching scientific literature

Guang Wang, Jia Liu, Ning Yang, Xia Gao, Hui Fan, Yuan Xu, Wenying Yang. PLoS One 2014
Times Cited: 15







List of co-cited articles
64 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.
Wenying Yang, Jie Liu, Zhongyan Shan, Haoming Tian, Zhiguang Zhou, Qiuhe Ji, Jianping Weng, Weiping Jia, Juming Lu, Jing Liu,[...]. Lancet Diabetes Endocrinol 2014
88
66

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2012
33


Weight beneficial treatments for type 2 diabetes.
L F Meneghini, D Orozco-Beltran, K Khunti, S Caputo, T Damçi, A Liebl, S A Ross. J Clin Endocrinol Metab 2011
62
26

Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
20

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.
M Hanefeld, M Cagatay, T Petrowitsch, D Neuser, D Petzinna, M Rupp. Eur Heart J 2004
455
20

Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial.
C Pan, W Yang, J P Barona, Y Wang, M Niggli, P Mohideen, Y Wang, J E Foley. Diabet Med 2008
124
20

Prevalence and control of diabetes in Chinese adults.
Yu Xu, Limin Wang, Jiang He, Yufang Bi, Mian Li, Tiange Wang, Linhong Wang, Yong Jiang, Meng Dai, Jieli Lu,[...]. JAMA 2013
20

Prevalence of diabetes among men and women in China.
Wenying Yang, Juming Lu, Jianping Weng, Weiping Jia, Linong Ji, Jianzhong Xiao, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji,[...]. N Engl J Med 2010
20

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
20



Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial.
Qingrong Pan, Yuan Xu, Ning Yang, Xia Gao, Jia Liu, Wenying Yang, Guang Wang. Medicine (Baltimore) 2016
12
25

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
Floris A van de Laar, Peter L Lucassen, Reinier P Akkermans, Eloy H van de Lisdonk, Guy E Rutten, Chris van Weel. Diabetes Care 2005
345
13

Post-meal coagulation activation in diabetes mellitus: the effect of acarbose.
A Ceriello, C Taboga, L Tonutti, R Giacomello, L Stel, E Motz, M Pirisi. Diabetologia 1996
103
13

Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
F Y Enç, N Imeryüz, L Akin, T Turoğlu, F Dede, G Haklar, N Tekeşin, N Bekiroğlu, B C Yeğen, J F Rehfeld,[...]. Am J Physiol Gastrointest Liver Physiol 2001
83
13


Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.
H Kawano, T Motoyama, O Hirashima, N Hirai, Y Miyao, T Sakamoto, K Kugiyama, H Ogawa, H Yasue. J Am Coll Cardiol 1999
541
13


Results from a dietary survey in an Indian T2DM population: a STARCH study.
Shashank R Joshi, Anil Bhansali, Sarita Bajaj, Subodh S Banzal, Mala Dharmalingam, Shachin Gupta, Satinath Mukhopadhyay, Parag R Shah, Rakesh Sahay, Swapan Sarkar,[...]. BMJ Open 2014
25
13



Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report.
Miao-yan Zheng, Ju-hong Yang, Chun-yan Shan, Hong-tao Zhou, Yan-guang Xu, Ying Wang, Hui-zhu Ren, Bao-cheng Chang, Li-ming Chen. Cardiovasc Diabetol 2013
42
13

Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics.
E Standl, G Schernthaner, J Rybka, M Hanefeld, S A Raptis, L Naditch. Diabetes Res Clin Pract 2001
23
13


Voglibose: an alpha glucosidase inhibitor.
Ajay S Dabhi, Nikita R Bhatt, Mohit J Shah. J Clin Diagn Res 2013
55
13

Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.
Matteo Monami, Valentina Vitale, Maria Luisa Ambrosio, Nadia Bartoli, Giulia Toffanello, Benedetta Ragghianti, Francesca Monami, Niccolò Marchionni, Edoardo Mannucci. Adv Ther 2012
60
13

Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes.
Shashank R Joshi, Ambady Ramachandran, Manoj Chadha, Sudip Chatterjee, Rahul Rathod, Sanjay Kalra. Expert Opin Pharmacother 2014
8
25

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. JAMA 2003
13

Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database.
Jianping Weng, Sidartawan Soegondo, Oliver Schnell, Wayne H-H Sheu, Wladyslaw Grzeszczak, Hirotaka Watada, Noriyuki Yamamoto, Sanjay Kalra. Diabetes Metab Res Rev 2015
23
13




Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose.
Po-Hsun Chen, Yi-Ting Tsai, Jun-Sing Wang, Shi-Dou Lin, Wen-Jane Lee, Shih-Li Su, I-Te Lee, Shih-Te Tu, Yao-Hsien Tseng, Wayne H-H Sheu,[...]. Diabetol Metab Syndr 2014
6
33

On the potential of acarbose to reduce cardiovascular disease.
Eberhard Standl, Michael J Theodorakis, Michael Erbach, Oliver Schnell, Jaakko Tuomilehto. Cardiovasc Diabetol 2014
38
13


Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.
Yanling Wu, Yanping Ding, Yoshimasa Tanaka, Wen Zhang. Int J Med Sci 2014
266
13

Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes.
Valmore Bermúdez, Raquel Cano, Clímaco Cano, Fernando Bermúdez, Elliuz Leal, Karen Acosta, Edgardo Mengual, Nailet Arraiz, Carlos Briceño, Juan Gómez,[...]. Am J Ther 2008
15
13

Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.
A Katsuki, Y Sumida, E C Gabazza, S Murashima, M Furuta, R Araki-Sasaki, Y Hori, Y Yano, Y Adachi. Diabetes Care 2001
262
13

Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.
Linong Ji, Dayi Hu, Changyu Pan, Jianping Weng, Yong Huo, Changsheng Ma, Yiming Mu, Chuanming Hao, Qiuhe Ji, Xingwu Ran,[...]. Am J Med 2013
114
13

The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
N Amador-Licona, J Guízar-Mendoza, E Vargas, G Sánchez-Camargo, L Zamora-Mata. Arch Med Res 2000
59
13

Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
John M Lachin, Giancarlo Viberti, Bernard Zinman, Steven M Haffner, R Paul Aftring, Gitanjali Paul, Barbara G Kravitz, William H Herman, Rury R Holman, Steven E Kahn. Clin J Am Soc Nephrol 2011
54
13


Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
A Keech, R J Simes, P Barter, J Best, R Scott, M R Taskinen, P Forder, A Pillai, T Davis, P Glasziou,[...]. Lancet 2005
13

Discordant associations of lipid parameters with albuminuria and chronic kidney disease: a population-based study.
Kan Sun, Diaozhu Lin, Feng Li, Chulin Huang, Yiqin Qi, Shengneng Xue, Juying Tang, Chuan Yang, Yan Li, Meng Ren,[...]. Lipids Health Dis 2015
14
14

Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.
Ying-Chun Ma, Li Zuo, Jiang-Hua Chen, Qiong Luo, Xue-Qing Yu, Ying Li, Jin-Sheng Xu, Song-Min Huang, Li-Ning Wang, Wen Huang,[...]. J Am Soc Nephrol 2006
13


Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
Scott M Grundy, James I Cleeman, Stephen R Daniels, Karen A Donato, Robert H Eckel, Barry A Franklin, David J Gordon, Ronald M Krauss, Peter J Savage, Sidney C Smith,[...]. Circulation 2005
13




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.